[
  {
    "ts": null,
    "headline": "Ken Washington appointed to TE Connectivity board of directors",
    "summary": "The board of directors of TE Connectivity plc (NYSE: TEL), a world leader in connectors and sensors, has appointed Ken Washington to the board, effective November 17, 2025.",
    "url": "https://finnhub.io/api/news?id=8f1e31cc94d9a346e790667d698f6771383c89142853d0f40b33a77b2ab359d0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762812900,
      "headline": "Ken Washington appointed to TE Connectivity board of directors",
      "id": 137437874,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The board of directors of TE Connectivity plc (NYSE: TEL), a world leader in connectors and sensors, has appointed Ken Washington to the board, effective November 17, 2025.",
      "url": "https://finnhub.io/api/news?id=8f1e31cc94d9a346e790667d698f6771383c89142853d0f40b33a77b2ab359d0"
    }
  },
  {
    "ts": null,
    "headline": "Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates",
    "summary": "Quanterix (QTRX) delivered earnings and revenue surprises of -56.52% and +4.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=03e16b9da754a53d4cb21b6739ab9226d43462093358e1cdff8570fd7e5a7e69",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762812602,
      "headline": "Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates",
      "id": 137437876,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Quanterix (QTRX) delivered earnings and revenue surprises of -56.52% and +4.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=03e16b9da754a53d4cb21b6739ab9226d43462093358e1cdff8570fd7e5a7e69"
    }
  },
  {
    "ts": null,
    "headline": "Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates",
    "summary": "Secured $147.6 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by $71.6 million in committed capital from Medtronic and Ligand, as well as $30 million from TerumoInitiated patient enrollments in the Virtue Trial evaluating Virtue® Sirolimus AngioInfusion™ Balloon (“Virtue SAB”) trial versus commercially available paclitaxel-coated balloon Demonstrated partnership-driven business model execution with",
    "url": "https://finnhub.io/api/news?id=9d2ca00df66f0cd17d7cd56f534740a2f104ca04db2086ffe05d64eebf283e2a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762809000,
      "headline": "Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates",
      "id": 137432877,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Secured $147.6 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by $71.6 million in committed capital from Medtronic and Ligand, as well as $30 million from TerumoInitiated patient enrollments in the Virtue Trial evaluating Virtue® Sirolimus AngioInfusion™ Balloon (“Virtue SAB”) trial versus commercially available paclitaxel-coated balloon Demonstrated partnership-driven business model execution with",
      "url": "https://finnhub.io/api/news?id=9d2ca00df66f0cd17d7cd56f534740a2f104ca04db2086ffe05d64eebf283e2a"
    }
  },
  {
    "ts": null,
    "headline": "Looking at the Changing Story for Medtronic After Analyst Upgrades and Board Shakeup",
    "summary": "Medtronic stock has seen its price target updated, with key financial assumptions reflecting both the company’s stable outlook and a slightly higher perception of risk. Improving analyst sentiment has supported this shift, as optimism grows around Medtronic’s product pipeline and strategic priorities. However, some experts remain watchful of potential near-term volatility. Read on to discover how you can stay informed about these evolving perspectives and what they might mean for the stock’s...",
    "url": "https://finnhub.io/api/news?id=b76e43894ae8f42cbe1b99ccd88d32e7769d5694fdb10d3ffb03501417c66bb2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762794869,
      "headline": "Looking at the Changing Story for Medtronic After Analyst Upgrades and Board Shakeup",
      "id": 137396705,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic stock has seen its price target updated, with key financial assumptions reflecting both the company’s stable outlook and a slightly higher perception of risk. Improving analyst sentiment has supported this shift, as optimism grows around Medtronic’s product pipeline and strategic priorities. However, some experts remain watchful of potential near-term volatility. Read on to discover how you can stay informed about these evolving perspectives and what they might mean for the stock’s...",
      "url": "https://finnhub.io/api/news?id=b76e43894ae8f42cbe1b99ccd88d32e7769d5694fdb10d3ffb03501417c66bb2"
    }
  },
  {
    "ts": null,
    "headline": "Competitor Analysis of Sports Medicine Market Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts 2024-2033",
    "summary": "The Sports Medicine industry is projected to grow significantly, reaching US$ 12.32 Billion by 2033 from US$ 7.27 Billion in 2024, marking a CAGR of 6.04%. This growth is driven by increased sports participation, a focus on injury prevention, and advancements in sports medicine technology like minimally invasive surgical tools. Companies such as Temple Ortho Biologics are pioneering solutions for young athletes. Leading market players include Zimmer Biomet, Medtronic, and Stryker, emphasizing in",
    "url": "https://finnhub.io/api/news?id=6c6ee9109d22bd9d8243077df73d5bfe91120fe439d6494a7eca715a37862dd8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762783800,
      "headline": "Competitor Analysis of Sports Medicine Market Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts 2024-2033",
      "id": 137395063,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The Sports Medicine industry is projected to grow significantly, reaching US$ 12.32 Billion by 2033 from US$ 7.27 Billion in 2024, marking a CAGR of 6.04%. This growth is driven by increased sports participation, a focus on injury prevention, and advancements in sports medicine technology like minimally invasive surgical tools. Companies such as Temple Ortho Biologics are pioneering solutions for young athletes. Leading market players include Zimmer Biomet, Medtronic, and Stryker, emphasizing in",
      "url": "https://finnhub.io/api/news?id=6c6ee9109d22bd9d8243077df73d5bfe91120fe439d6494a7eca715a37862dd8"
    }
  },
  {
    "ts": null,
    "headline": "ISRG Stock Gains More than 28% in a Month: Should You Buy, Hold or Sell?",
    "summary": "Intuitive Surgical's shares soar over 28% in a month on da Vinci 5 momentum, but margin and valuation pressures suggest caution for new buyers.",
    "url": "https://finnhub.io/api/news?id=e8c16b0384a4ecb366b1ac5f45d5f57fb5bd2e6e8fe6d517a4367a89c6a7cb2f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762778820,
      "headline": "ISRG Stock Gains More than 28% in a Month: Should You Buy, Hold or Sell?",
      "id": 137394979,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Intuitive Surgical's shares soar over 28% in a month on da Vinci 5 momentum, but margin and valuation pressures suggest caution for new buyers.",
      "url": "https://finnhub.io/api/news?id=e8c16b0384a4ecb366b1ac5f45d5f57fb5bd2e6e8fe6d517a4367a89c6a7cb2f"
    }
  }
]